Tablets & Capsules

TC0116

Issue link: https://www.e-digitaleditions.com/i/626800

Contents of this Issue

Navigation

Page 61 of 77

TO LEARN MORE VISIT OUR WEBSITE AT WWW.CROWNIRON.COM OR CALL (651) 639-8900 TIRED OF BATCHING IT? …Extractions that is. LOOKING FOR A STEADY DATE? …We mean continuous. Meet the Model IV & Model V Continuous Extractors from Crown. Extracting Nutraceuticals for over 20 years. Pilot Plant Available. DCAT Week. March 14-17 in New York, NY. Conducted by the Drug, Chemical, & Associated Technologies Association. Tel. 609 208 1888. Website: www.dcat.org. Drug Development and Clinical Science Course. March 14-18 in Philadelphia, PA. Conducted by Society of Clinical Research Associates. Tel. 800 762 7292. Website: www.socra.org. Dubai International Pharmaceuticals and Technologies Conference and Exhi- bition. March 15-17 in Dubai, United Arab Emirates. Tel. +971 4362 4717. Website: www.duphat.ae. The Manufacturing Process. March 16- 18 in Cleveland, OH. Conducted by Techceuticals. Tel. 216 658 8038. Web- site: www.techceuticals.com. Annual Nutrition & Health Conference. March 21-23 in Denver, CO. Conducted by the University of Arizona Health Sci- ences Center and the Arizona Center for Integrative Medicine. Tel. 520 544 2938. Website: www.nutritionandhealthconf. org. Infarma. March 24-26 in Madrid, Spain. Conducted by Interalia and Colegio Ofi- cial de Farmacéuticos de Madrid. Tel. +34 934 161 466. Website: www.infarma.es. CPhI Russia. March 30-April 1 in Moscow, Russia. Conducted by Interna- tional UBM. Tel. +31 204 099 544. Web- site: www.cphi.com. 52 January 2016 Tablets & Capsules supplier news Capsugel to acquire Xcelience, Powdersize MORRISON, NJ—Capsugel agreed to acquire Xcelience, Tampa, FL, and Powdersize, Quakertown, PA, and will incorporate them into its Dosage Form Solutions business. Xcelience offers clinical development services, manufacturing, packaging, labeling and distribution. It opened a 71,000-square-foot headquarters last year. Powdersize provides micronizing and particle-engineering services to improve bioavailability. Prior to the Capsguel agreement, Xcelience had agreed to make a structured cash investment in Powdersize. In recent years, Capsugel has acquired a few companies outside its traditional busi- ness of supplying empty capsules, including Bend Research, Encap, and Xcelodose. SPI Pharma, Asahi Kasei to cross- distribute excipients WILMINGTON, DE—SPI Pharma and the functional additives division of Asahi Kasei, Tokyo, Japan, agreed to co-market one another's pharmaceuti- cal ingredients in their home markets. SPI Pharma is now the exclusive dis- tributor in the USA and Canada of specialty grades of Ceolus and Celphere microcrystalline cellulose spherical seed cores. Asahi Kasei is the exclusive distributor in Japan of Mannogem mannitol and Pharmaburst, a co-processed group of excipients for making orally disintegrating tablets. Marine Ingredients to acquire Florida softgel facility STARNBERG, Germany—Aenova Group agreed to sell Swiss Caps USA's

Articles in this issue

Links on this page

Archives of this issue

view archives of Tablets & Capsules - TC0116